GILD Oct 2024 65.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:53AM EDT. Market open.
| Previous close | 0.0200 |
| Open | 0.0100 |
| Bid | 0.0000 |
| Ask | 0.2300 |
| Strike | 65.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.0100 - 0.0200 |
| Contract range | N/A |
| Volume | |
| Open interest | 454 |
ZacksGilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know
Gilead Sciences (GILD) reachead $85.21 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.
Business WireGilead Presents Additional Efficacy, Safety and Demographic Data From PURPOSE 2 Trial at 5th HIV Research for Prevention Conference
FOSTER CITY, Calif., October 07, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) providing an overview of the efficacy and safety of twice-yearly lenacapavir, the company’s injectable HIV-1 capsid inhibitor, for the investigational use of HIV prevention among a broad and geographically diverse range of cisgender men and gender-diverse people.
Simply Wall St.Gilead Sciences' (NASDAQ:GILD) investors will be pleased with their favorable 62% return over the last five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...
© 2024 Yahoo. All rights reserved.